ABM Industries (ABM)
(Delayed Data from NYSE)
$51.30 USD
+0.12 (0.23%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $51.29 -0.01 (-0.02%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth C Momentum A VGM
Price, Consensus and EPS Surprise
ABM 51.30 +0.12(0.23%)
Will ABM be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for ABM based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ABM
ABM Industries Stock Rises 16% in Six Months: Here's Why
AngioDynamics Stock Up on Q1 Earnings Beat, Y/Y Pro-Forma Sales Rise
ABM: What are Zacks experts saying now?
Zacks Private Portfolio Services
Reasons to Add Avanos Medical Stock in Your Portfolio Now
Reasons to Retain GE HealthCare Stock in Your Portfolio Now
SYK Stock May Gain From Completion of Vertos Medical Acquisition
Other News for ABM
ABM Industries: Sailing Secular Tailwinds With Its Resilient, Capital-Lite Ship
ABM Industries: The Recent Pullback Could Be A Good Entry Point For A Long Position
ABM Industries About To Put More Money In Your Pocket (ABM)
UGI Corporation Appoints Melanie Ruiz and David Bingenheimer to its Board of Directors
Dividend Champion, Contender, And Challenger Highlights: Week Of September 29